Your browser doesn't support javascript.
loading
Daclizumab induction as an immunosuppressive regimen for renal transplant recipients from non-heart-beating donors.
Sánchez-Fructuoso, A I; Prats, D; Marques, M; Ridao, N; Conesa, J; García Mena, M; Torrente, J; Barrientos, A.
Affiliation
  • Sánchez-Fructuoso AI; Department of Nephrology, Hospital Clínico San Carlos, Madrid, Spain. sanchezfruct@telefonica.net
Transplant Proc ; 35(5): 1689-90, 2003 Aug.
Article in En | MEDLINE | ID: mdl-12962759
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / Immunoglobulin G / Kidney Transplantation / Heart Arrest / Immunosuppressive Agents / Antibodies, Monoclonal / Mycophenolic Acid Type of study: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplant Proc Year: 2003 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / Immunoglobulin G / Kidney Transplantation / Heart Arrest / Immunosuppressive Agents / Antibodies, Monoclonal / Mycophenolic Acid Type of study: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplant Proc Year: 2003 Document type: Article Affiliation country: Country of publication: